Sorry, you need to enable JavaScript to visit this website.
Personalized medicine project in patients undergoing percutaneous coronary interventions

Personalized medicine project in patients undergoing percutaneous coronary interventions

EDINBURG – Can a medical tool predict the risk of certain medications based on a patient’s genetics, and, if so, could this information lead to doctors customizing a patient’s drug therapy? The tool being studied at DHR Health Institute for Research & Development to answer these questions is Cipherome’s Xentinel® Lighthouse, and this pilot study will also evaluate the resulting savings in healthcare costs. After a stroke or heart attack, the standard treatment is Percutaneous Coronary Intervention (PCI), or stent placement. A stent opens blood vessels in the heart that have narrowed due to the buildup of plaque. Following PCI, doctors typically prescribe aspirin and a P2Y12 ...

PLEASE LOG IN FOR PREMIUM CONTENT. Our website requires visitors to log in to view the best local news. Not yet a subscriber? Subscribe today!

Advance Publishing Company

217 W. Park Avenue
Pharr, TX 78577